KCa3.1 upregulation was caused by an altered sphingolipid profile via a H2O2/Fyn-mediated pathway during the aging process, whereas globotriaosylceramide downregulated KCa3.1 in Fabry disease [14]. Here, KCNN4 is linked to Fabry disease.